Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Refining esophageal cancer staging.

Thomas W Rice1, Eugene H Blackstone, Lisa A Rybicki

  • 1Center for Swallowing and Esophageal Disorders, Departments of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. ricet@ccf.org

The Journal of Thoracic and Cardiovascular Surgery
|May 29, 2003
PubMed
Summary

Current esophageal cancer staging by the American Joint Committee on Cancer (AJCC) is inadequate. Refinements in T1, N1, and M1 classifications are needed for more accurate prognosis and improved cancer staging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quality of Life in Patients With p16+ Oropharyngeal Cancer Receiving Accelerated Radiation Therapy With Either Cisplatin or Cetuximab in the NRG/RTOG 1016 Randomized Controlled Trial.

International journal of radiation oncology, biology, physics·2026
Same author

Self-Perceived Hearing Outcomes With Radiation and Cisplatin or Radiation and Cetuximab for Patients With Human Papilloma Virus (HPV)-Positive Oropharyngeal Cancer-Results From NRG Oncology RTOG 1016.

International journal of radiation oncology, biology, physics·2025
Same author

Image analysis reveals differences in tumor multinucleations in Black and White patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.

Cancer·2022
Same author

A Reappraisal of Definitive Chemoradiotherapy for Older Adults With Advanced Head and Neck Cancer.

Anticancer research·2022
Same author

Prognostic value of computed tomography scan detection of cartilage invasion in advanced laryngeal cancer treated with primary total laryngectomy.

Head & neck·2022
Same author

Primary Total Laryngectomy versus Organ Preservation for Locally Advanced T3/T4a Laryngeal Cancer.

The Laryngoscope·2022

Area of Science:

  • Oncology
  • Cancer Research
  • Medical Statistics

Background:

  • Cancer staging systems require dynamic updates based on accumulating clinical knowledge and treatment experience.
  • Accurate staging is crucial for effective treatment planning and prognosis in esophageal cancer.

Purpose of the Study:

  • To evaluate the adequacy of the current American Joint Committee on Cancer (AJCC) staging system for esophageal cancer.
  • To determine if refinements in classification and stage grouping are necessary for improved accuracy.

Main Methods:

  • Analysis of survival data from 480 patients who underwent esophagectomy without induction therapy (1983-2000).
  • Utilized survival-tree analysis, multivariable Cox regression, and residual misclassification risk analysis.
  • Examined depth of tumor invasion (T), regional lymph node status (N), distant status (M), metastatic lymph node count, histopathologic type, and grade.

Related Experiment Videos

Main Results:

  • Identified inhomogeneity and lack of distinction within current AJCC staging groups.
  • Redefined T1 (T1a: intramucosal, T1b: submucosal) and N1 (N1: 1-2 nodes, N2: 3+ nodes) based on significant survival differences (P=.008 and P=.01, respectively).
  • Found current M1 subclassification unwarranted (P=.9) and histopathologic type/grade minimally impactful on staging (P=.17 and P=.3).

Conclusions:

  • The current AJCC staging for esophageal cancer is inadequate.
  • Refinement necessitates redefinition of T1, N1, and M1 classifications.
  • Stage grouping within AJCC constraints yielded less accurate prognosis compared to free assignment based on survival data.